price apr usd
buy rate reflect increas confid revenu earn
acceler stori result compani meaning beat organ
sale growth estim support thesi
thing like
 solid organ sale growth beat organ sale growth
materi beat estim consensu growth
surpass forecast three four segment vs dbe life scienc
diagnost environment appli growth
dental came forecast
 strength china continu posit tone outlook report
doubl digit growth dd china mark consecut quarter
dd growth growth broad-bas across portfolio four
regard outlook china
pall life scienc busi driven healthi biotech custom
demand specif manag call continu strength
singl use technolog includ robust demand pall icelli
bioreactor system gene therapi addit biopharma custom
demand sciex busi good
thing cautiou
 europ laggard tone remain cautiou western europ grew
low-single-digit pace laggard compar major
geograph region manag note stabil also
convey cautiou tone relat outlook
item pick dx margin sciex growth oper margin
diagnost segment deterior basi point bp y/i despit
post mid-single-digit growth quarter manag attribut
sever factor includ advers fx impact china tariff neg
mix shift cepheid growth deceler meaning vs strong prior-year
flu season beckman dx growth acceler sciex growth slow
low-single-digit pace follow four consecut quarter high-single-
deutsch bank seek busi compani cover research report thu investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis disclosur analyst certif locat
distribut gmt
includ tough compar north america clinic custom end
rais pt
rais pt reflect higher multipl roll for-
ward valuat framework price target reflect enterpris
valu use project level debt cash ttm
ebitda ex option multipl modest premium life scienc tool
peer group median ev/ftm ebitda ex option price target also con-
templat pro-forma financi ramif announc acquisit
ge biopharma busi ipo dental busi
forecast ratio
period end expense/ incom expense/ incom incom ep share share sale omx cash flow oper cash cash deploy
period end asset cash account receiv expens current current equip intang asset liabil note payabl current portion lt account expens current lt liabil stockhold april
price current end previou trade session unless otherwis indic sourc local exchang via reuter bloomberg vendor
inform sourc deutsch bank subject compani sourc disclosur pertain recommend estim made secur primari
subject research pleas see recent publish compani report visit global disclosur look-up page websit http //research db com/research/disclosures/
companysearch asid within report import risk conflict disclosur also found investor
strongli encourag review inform invest
import disclosur requir regul
